Barinthus Biotherapeutics plc(BRNS)
Biotechnology
Immunology & Autoimmune Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2023-06-28 | Scheeren Joseph Director | Purchase | +10,000 | +76.92%23,000 | $2.44 | $24,400 | View SEC filing | |
| 2023-06-01 | Wright Robin Director | Purchase | +13,750 | +39.85%48,256 | $2.66 | $36,612 | View SEC filing | |
| 2023-03-29 | Enright William Chief Executive Officer | Sale | -15,000 | -2.02%728,454 | $2.42 | $36,299 | View SEC filing | |
| 2022-08-26 | Griffiths Graham Chief Business Officer | Sale | -10,000 | -8.76%104,209 | $7.39 | $73,870 | View SEC filing | |
| 2022-08-26 | Ellis Christopher Chief Operating Officer | Sale | -39,626 | -85.71%75 | $6.55 | $259,548 | View SEC filing | |
| 2022-08-19 | Ellis Christopher Chief Operating Officer | Sale | -2,824 | -89.64%75 | $4.82 | $13,624 | View SEC filing | |
| 2022-08-19 | Griffiths Graham Chief Business Officer | Sale | -500 | -0.44%114,209 | $4.76 | $2,381 | View SEC filing | |
| 2022-08-17 | Ellis Christopher Chief Operating Officer | Sale | -7,550 | -98.62%75 | $4.77 | $35,976 | View SEC filing | |
| 2022-08-17 | Griffiths Graham Chief Business Officer | Sale | -3,620 | -3.06%114,709 | $4.77 | $17,284 | View SEC filing | |
| 2022-08-15 | Griffiths Graham Chief Business Officer | Sale | -5,000 | -4.05%118,329 | $4.50 | $22,500 | View SEC filing | |
| 2022-07-15 | Ellis Christopher Chief Operating Officer | Sale | -5 | -6.25%75 | $6.00 | $30 | View SEC filing | |
| 2022-07-15 | Griffiths Graham Chief Business Officer | Sale | -8 | -0.01%123,229 | $5.28 | $42 | View SEC filing | |
| 2022-04-04 | Scheeren Joseph Director | Purchase | +10,000 | +333.33%13,000 | $5.09 | $50,900 | View SEC filing | |
| 2022-04-04 | Hammacher Alex Director | Purchase | +2,000 | +200.00%3,000 | $5.14 | $10,280 | View SEC filing | |
| 2022-01-04 | Hammacher Alex Director | Purchase | +1,000 | +100.00%1,000 | $10.86 | $10,860 | View SEC filing | |
| 2021-12-23 | Wright Robin Director | Purchase | +10,000 | +40.81%34,506 | $9.97 | $99,700 | View SEC filing | |
| 2021-05-06 | DAWES KAREN A Director | Purchase | +1,700 | +100.00%1,700 | $17.00 | $28,900 | View SEC filing | |
| 2021-05-06 | Griffiths Graham Chief Business Officer | Purchase | +100 | +100.00%100 | $17.00 | $1,700 | View SEC filing | |
| 2021-05-06 | Wright Robin Director | Purchase | +14,000 | +133.26%24,506 | $17.00 | $238,000 | View SEC filing | |
| 2021-05-06 | Ellis Christopher Chief Operating Officer | Purchase | +75 | +100.00%75 | $17.00 | $1,275 | View SEC filing | |
| 2021-05-06 | Scheeren Joseph Director | Purchase | +3,000 | +100.00%3,000 | $17.00 | $51,000 | View SEC filing | |
| 2021-05-06 | Phillips Anne M. Director | Purchase | +3,000 | +100.00%3,000 | $17.00 | $51,000 | View SEC filing | |
| 2021-05-06 | Oxford Sciences Innovation plc 10% Owner | Purchase | +600,000 | +7.32%8,797,770 | $17.00 | $10,200,000 | View SEC filing | |
| 2021-05-03 | M&G INVESTMENT MANAGEMENT LTD 10% Owner | Purchase | +125,000 | +12.97%1,088,597 | $14.40 | $1,800,000 | View SEC filing |
1-24 of 24